Investment Review day 6 of 50: PubMatic
Investment Review day 6 of 50: PubMatic Inc PubMatic is one of America’s fastest-growing programmatic advertising supply side platforms (SSPs). It helps publishers get the highest rates possible in placing advertisements on their websites, podcasts, or Connected TV (CTV) stations. PubMatic participates in trillions of digital auctions every day to
Investment Review day 5 of 50: JD.com $JD
Investment Review day 5 of 50: JD.com $JD JD.com is an e-commerce leader in its home market of China. The company stands out with its emphasis on quality goods and exceptional customer service, fueled by its own advanced logistics and fulfillment infrastructure, giving it strong control over the customer experience
E17: Google – Bull, Bear, or Dodo? + Diversification Dilemma
Is Google $GOOGL a bear, a bull or a dodo? Badger buys more, Monkey screeches Be Careful! Meta $META was in a similar position not too long ago, but it has an impenetrable social network moat. Can the same thing be said of Google’s data in a time of AI
Investment Review day 4 of 50: Airtel Africa $AARTY
Investment Review day 4 of 50: Airtel Africa $AARTY Airtel Africa is a dominant player in sub-Saharan Africa’s telecom and mobile money sectors. A region that has low banking penetration but high mobile connectivity – a recipe for disruption. Airtel holds significant market share across Africa, and their expansion into
Investment Review day 3 of 50: Guardant Health $GH #cancerdetection #liquidbiopsy
Investment Review day 3 of 50: Guardant Health $GH Guardant Health is at the forefront of liquid biopsy innovation. Their blood tests enable early cancer detection via the analysis of circulating tumor DNA. This has the potential to revolutionize patient outcomes. Guardant is a key holding in my healthcare portfolio,
Investment Review day 2 of 50: Nano-X Imaging $NNOX – a medtech innovator disrupting x-rays
Investment Review day 2 of 50: Nano-X Imaging $NNOX This med-tech innovator is disrupting the x-ray market with a far smaller, more portable device. 510(k) FDA clearance in May ’23 was a major turning point. Initially a 0.5% long-shot bet in 2021, Nano-X was heading for the ‘Theranos’ pile. FDA
Investment Review day 1 of 50: Nuscale Power $SMR
Investment Review day 1 of 50: Nuscale Power $SMR NuScale Power is an industry-leading provider of advanced nuclear small modular reactor #SMR technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free nuclear power. I added a small venture position in NuScale
E16: NVIDIA Dominates, Enovix Disrupts – Earnings Analysis & Market Moves
NVIDIA ($NVDA) just dropped record earnings, again, sending the stock market into a frenzy! The results were off the charts, defying expectations and adding billions to the company’s market value. But are things truly as rosy as they look? We’ll dissect the numbers and get to the bottom of it.
Palo Alto Networks $PANW is down over 25% overnight – in this video we’ll tell you why!
Palo Alto Networks $PANW is the world’s largest pure play cyber security company. But the stock is down over 25% overnight – in this video we’ll tell you why! A key competitor is reporting in two weeks time, and it’s a company in the same sector, with a more modern
E15: Bubble Trouble – Are Semiconductors Set to Burst?
Do you smell a bubble brewing? Join Badger and Monkey in a lively market breakdown where we crack open the wild world of market bubbles. We’ll teach you how to spot these dangerous inflations and protect your portfolio from a devastating pop. Are we in a semiconductor bubble? Is Nvidia